EUVIMEDEUVIMED entdecken
Crossref

Tirzepatide Lowered Blood Pressure in People With Obesity

Emily Harris

JAMA · 12.03.2024 · 331 (10) · 821

DOI: 10.1001/jama.2024.0726 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, erschienen am 12.03.2024. Verfasst von Emily Harris. Hauptthemen laut MEDLINE: Blood Pressure, Obesity, Antihypertensive Agents, Hypertension. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Blood PressureObesityAntihypertensive AgentsHypertensionHumansDiabetes Mellitus, Type 2Gastric Inhibitory PolypeptideGlucagon-Like Peptide-2 ReceptorHypoglycemic AgentsTirzepatide

Substanzen

Gastric Inhibitory PolypeptideGlucagon-Like Peptide-2 ReceptorHypoglycemic AgentsTirzepatideAntihypertensive Agents

Zitieren

APA

Harris, E. (2024). Tirzepatide Lowered Blood Pressure in People With Obesity. JAMA, 331(10), 821. https://doi.org/10.1001/jama.2024.0726

Vancouver

Harris E. Tirzepatide Lowered Blood Pressure in People With Obesity. JAMA. 2024;331(10):821. doi:10.1001/jama.2024.0726

BibTeX
@article{Harris2024,
  author = {Harris, Emily},
  title = {Tirzepatide Lowered Blood Pressure in People With Obesity},
  journal = {JAMA},
  year = {2024},
  volume = {331},
  number = {10},
  pages = {821},
  doi = {10.1001/jama.2024.0726}
}
Kostenlos starten →